ADVENZYMES — Advanced Enzyme Technologies Share Price
0.000.00%
Last trade - 00:00- IN₹31.58bn
- IN₹27.29bn
- IN₹6.24bn
- 91
- 27
- 34
- 51
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.51 | ||
| PEG Ratio (f) | 0.76 | ||
| EPS Growth (f) | 27.61% | ||
| Dividend Yield (f) | 0.32% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.35 | ||
| Price to Tang. Book | 3.3 | ||
| Price to Free Cashflow | 33.06 | ||
| Price to Sales | 5.03 | ||
| EV to EBITDA | 14.44 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.61% | ||
| Return on Equity | 10.27% | ||
| Operating Margin | 24.43% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 4,439.86 | 5,018.41 | 5,293.83 | 5,406.37 | 6,238.68 | 6,715 | 7,884 | 8.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +16.39 | +10.29 | -16.85 | -7.57 | +31.69 | +3.71 | +27.61 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Advanced Enzyme Technologies Limited is an India-based company, engaged in manufacturing enzymes and probiotics. The Company is focused on the research and development, manufacturing, and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. It provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit, and vegetable processing, brewing, and malting, grain processing, protein modification, dairy processing, textile processing, and others. It offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather, and biofuels. Its oils and fats processing include oil extraction, oil refining, and others.
Directors
- Kedar Desai NEC (44)
- Beni Rauka CFO (51)
- Piyush Rathi CMO (36)
- Prabal Bordiya CCO (23)
- Dipak Roda VPR (43)
- Anil Gupta VRD (51)
- Chandrakant Rathi MDR (61)
- Bhaskar Manolkar GMG (57)
- Mukund Kabra EDR (43)
- Animesh Bagchi OTH (47)
- Pradeep Bhosale OTH (46)
- Rahul Kirkinde OTH (41)
- Rajendra Newase OTH (52)
- Satish Pagar OTH (47)
- Vikas Toshniwal OTH (40)
- Rasika Rathi NED
- Vasant Rathi NED (67)
- Pradip Shah NED (62)
- Sunny Sharma NED (47)
- Vinodkumar Jajoo IND
- Rajshree Patel IND
- Pramod Kasat NID
- Ramesh Mehta NID (83)
- Suresh Paharia NID
- Rajesh Sharma NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 15th, 1989
- Public Since
- August 1st, 2016
- No. of Shareholders
- 69,926
- No. of Employees
- 323
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 111,881,150
- Address
- Sun-Magnetica, A Wing, 5th Floor, THANE, 400604
- Web
- https://www.advancedenzymes.com/
- Phone
- +91 2241703200
- Contact
- Ronak Saraf
- Auditors
- MSKA & Associates
Upcoming Events for ADVENZYMES
Advanced Enzyme Technologies Ltd Annual Shareholders Meeting
Q1 2026 Advanced Enzyme Technologies Ltd Earnings Release
Similar to ADVENZYMES
20 Microns
National Stock Exchange of India
Aarti Industries
National Stock Exchange of India
Aarti Surfactants
National Stock Exchange of India
Abm International
National Stock Exchange of India
Aeron Composite
National Stock Exchange of India
FAQ
What is the Advanced Enzyme Technologies share price?
As of Today at 07:05 UTC, shares in Advanced Enzyme Technologies are trading at IN₹282.25. This share price information is delayed by 15 minutes.
How has the Advanced Enzyme Technologies share price performed this year?
Shares in Advanced Enzyme Technologies last closed at IN₹282.25 and the price had moved by -28.63% over the past 365 days. In terms of relative price strength the Advanced Enzyme Technologies share price has underperformed the S&P BSE 100 Index by -32.95% over the past year.
What are the analyst and broker recommendations for Advanced Enzyme Technologies?
The overall consensus recommendation for Advanced Enzyme Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Advanced Enzyme Technologies dividend yield?
The Advanced Enzyme Technologies dividend yield is 1.81% based on the trailing twelve month period.
Does Advanced Enzyme Technologies pay a dividend?
Last year, Advanced Enzyme Technologies paid a total dividend of IN₹5.10, and it currently has a trailing dividend yield of 1.81%. We do not have any data on when Advanced Enzyme Technologies is to next pay dividends.
When does Advanced Enzyme Technologies next pay dividends?
We do not have data on when Advanced Enzyme Technologies is to next pay dividends. The historic dividend yield on Advanced Enzyme Technologies shares is currently 1.81%.
How do I buy Advanced Enzyme Technologies shares?
To buy shares in Advanced Enzyme Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Advanced Enzyme Technologies?
As of the previous close price of IN₹282.25, shares in Advanced Enzyme Technologies had a market capitalisation of IN₹31.58bn.
Where are Advanced Enzyme Technologies shares listed?
Here are the trading details for Advanced Enzyme Technologies:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ADVENZYMES
What kind of share is Advanced Enzyme Technologies?
Based on an overall assessment of its quality, value and momentum Advanced Enzyme Technologies is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Advanced Enzyme Technologies share price forecast for 2025?
The analyst consensus target price for shares in Advanced Enzyme Technologies is IN₹380.00. That is 34.63% above the last closing price of IN₹282.25.
Analysts covering Advanced Enzyme Technologies currently have a consensus Earnings Per Share (EPS) forecast of IN₹13.40 for the next financial year.
Find out moreWhat is the trend in the Advanced Enzyme Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Advanced Enzyme Technologies. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -41.13%.
As of the last closing price of IN₹282.25, shares in Advanced Enzyme Technologies were trading -25.98% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Advanced Enzyme Technologies PE Ratio?
The Advanced Enzyme Technologies PE ratio based on its reported earnings over the past 12 months is 16.51. The shares last closed at IN₹282.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Advanced Enzyme Technologies?
Advanced Enzyme Technologies' management team is headed by:
- Kedar Desai - NEC
- Beni Rauka - CFO
- Piyush Rathi - CMO
- Prabal Bordiya - CCO
- Dipak Roda - VPR
- Anil Gupta - VRD
- Chandrakant Rathi - MDR
- Bhaskar Manolkar - GMG
- Mukund Kabra - EDR
- Animesh Bagchi - OTH
- Pradeep Bhosale - OTH
- Rahul Kirkinde - OTH
- Rajendra Newase - OTH
- Satish Pagar - OTH
- Vikas Toshniwal - OTH
- Rasika Rathi - NED
- Vasant Rathi - NED
- Pradip Shah - NED
- Sunny Sharma - NED
- Vinodkumar Jajoo - IND
- Rajshree Patel - IND
- Pramod Kasat - NID
- Ramesh Mehta - NID
- Suresh Paharia - NID
- Rajesh Sharma - NID